Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Deflazacort induced stronger immunosuppression than expected.

Rocio E Gonzalez-Castañeda1, Estela Adriana Castellanos-Alvarado, Maria Rosa Flores-Marquez

  • 1Neuroscience Division, Centro de Investigación Biomédica de Occidente del Instituto Mexicano del Seguro Social, Guadalajara, Mexico.

Clinical Rheumatology
|June 2, 2006
PubMed
Summary

Deflazacort (DFZ) caused higher mortality and immunosuppression than prednisone (PDN) in rats, but resulted in significantly less neuronal degeneration in the brain. Further clinical studies on DFZ

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

REM sleep deprivation during mid-pregnancy alters exploratory behaviors in dams and induces locomotor hyperactivity in mouse offspring.

Behavioural processes·2026
Same author

EQUATOR reporting guideline use and editorial enforcement in four medical specialties: a cross-sectional study of 20 high-impact journals.

BMC medical research methodology·2026
Same author

Automated Facial Emotion Recognition System Detects Altered Emotional Processing During Craving Induction in Individuals with Substance Use Disorder.

Healthcare (Basel, Switzerland)·2026
Same author

The Unasked Question: Musculoskeletal Symptoms in Sexual Activity.

The Journal of rheumatology·2026
Same author

Novel RSAD2 isoforms lacking antiviral activities are originated from alternative splicing and expressed in patients with rheumatic diseases.

Biochimica et biophysica acta. Molecular basis of disease·2025
Same author

Impact of incorrect affiliations on the recognition of Mexican scientific institutions.

Revista medica del Instituto Mexicano del Seguro Social·2025

Area of Science:

  • Neuroscience
  • Pharmacology
  • Toxicology

Background:

  • Prednisone (PDN) is known to impair cognitive function and brain structures.
  • Deflazacort (DFZ) is a synthetic glucocorticoid with a purported lower side-effect profile than PDN.
  • Understanding the comparative neurotoxic and immunomodulatory effects of PDN and DFZ is crucial for clinical application.

Purpose of the Study:

  • To compare the effects of chronic administration of DFZ versus PDN on neuronal degeneration and glial reactivity in the rat brain.
  • To evaluate potential differences in mortality rates and systemic immunosuppression between DFZ and PDN treatments.

Main Methods:

  • Male Swiss-Wistar rats were administered either DFZ (6 mg/kg/day), PDN (5 mg/kg/day), or distilled water (control) orally for 90 days.

Related Experiment Videos

  • Neuronal degeneration and glial (astrocyte and microglia) reactivity were assessed in the prefrontal cortex and hippocampus (CA1, CA3).
  • Mortality rates and signs of systemic infection were monitored throughout the study.

    • Main Results:

    • The DFZ group exhibited significantly higher overall mortality (49%) compared to the PDN group (4.5%) and controls (0%), with infections noted in multiple organs.
    • PDN treatment resulted in substantially higher neuronal degeneration in the prefrontal cortex, CA1, and CA3 hippocampus compared to controls and the DFZ group.
    • Both PDN and DFZ increased astrocyte reactivity, while DFZ showed a marked reduction in microglial cell numbers compared to controls and PDN.

    Conclusions:

    • At equivalent licensed doses, DFZ demonstrates a stronger immunosuppressive effect, both systemically and within brain tissue, than PDN.
    • Despite higher mortality, DFZ induced less neuronal damage in the studied brain regions compared to PDN.
    • Further clinical investigation into the immunosuppressive magnitude of DFZ is warranted.